International Journal of Cardiology
Volume 76, Issue 2 , Pages 122-124 , November 2000

The significance of Leptin in human — do we know it yet?

  • Wolfram Doehner

      Affiliations

    • National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London SW3 6LY, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-20-7351-8127; fax: +44-20-7351-8733
  • ,
  • Stefan D Anker

      Affiliations

    • National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London SW3 6LY, UK
    • Franz Volhard Klinik (Charité) at Max Delbrück Zentrum, Berlin, Germany

References 

  1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432
  2. Stenvinkel P, Lonnqvist F, Schalling M. Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant. 1999;14:l 103–1112
  3. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al  Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83:1263–1271
  4. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379:632–635
  5. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes. 1997;46:313–316
  6. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997;82:1293–1300
  7. Filippatos GS, Tsilias K, Venetsanou K, Karambinos D, Manolatos D, Kranadis A, et al. Editorial for the manuscript: Leptin serum levels in cachectic heart failure patients: Relationship with tumor necrose factor. Int J Cardiol. 2000;76
  8. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J. 1998;19:1547–1551
  9. Bottner A, Eisenhofer G, Friberg P, Rundqvist B, Bornstein SR. Hyperleptinaemia does not correlate with plasma catecholamine levels in chronic heart failure. Eur Heart J. 1999;20:1051–1052
  10. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism. 1997;46:450–453
  11. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart. 1999;82:352–356
  12. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and inimune and neuroendocrine activation. Chest. 1999;115(3):836–847
  13. Anker SD, Clark AL, Teixeira MM, Hellewell PG, Coats AJ. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol. 1999;83(4):612–615
  14. Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol. 1997;29:1214–1220
  15. Qian H, Azain MJ, Compton MM, Hartzell DL, Hausman GJ, Baile CA. Brain administration of leptin causes deletion of adipocytes by apoptosis. Endocrinology. 1998;139:791–794
  16. Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez-Williams G, et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood. 1999;93:1668–1676
  17. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA. 1998;95:9558–9561
  18. Tsuchiya T, Shimizu H, Hone T, Mori M. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol. 1999;365(2–3):273–279

PII: S0167-5273(00)00396-X

International Journal of Cardiology
Volume 76, Issue 2 , Pages 122-124 , November 2000